You may find more results for this query on our sister sites: 360Dx and Precision Oncology News.
The synthetic biology firm had total revenues of $19.3 million and withdrew its financial guidance for fiscal year 2020 citing uncertainty caused by COVID-19.
The company holds and licenses a variety of IP related to high-throughput genotyping, sample pooling, and methods involved in oligonucleotide ligation-based assays.
Some of the market's most influential voices, including Kári Stefánsson and Linda Avey, believe that consumer genomics is not on the way out but rather experiencing a period of transition.
The genome mapping firm's instrument revenues were down 50 percent year over year in the fourth quarter, offset by an increase in consumables revenue.
UK-based Abcam has acquired Oregon-based life science research tool provider Marker Gene Technologies, the latest in a string of asset purchases.
The Cambridge, UK-based gene synthesis firm plans to use the funds to accelerate development of its silicon platform and introduce a desktop device.
LGC will be Swift's worldwide partner for amplicon-based targeted sequencing assays for genotyping AgBio samples, including crop species and animals.
The offering of common stock will be the second for Twist this year and the third since the company made its initial public offering in October 2018.
A hearing scheduled for Friday, part of a lawsuit filed by Agilent was cancelled, leading to speculation the sides were close to a settlement.
Assemblies of two basmati rice genomes enabled researchers to trace the origins of the rice variety and could help pinpoint desired rice genes for breeding.
The UK's Biosearch Technologies will distribute Arbor Biosciences' myBaits custom, targeted NGS panels to agricultural and seed breeding companies.
Researchers from UBC, the BC Centre for Disease Control, and elsewhere will conduct a multi-omics study of the foodborne pathogen.
The deal covers distribution of certain of Primerdesign's molecular testing products to the aquaculture and aquamarine markets in France.
Illumina, Twist Bioscience, and DNA Script are among the private sector collaborators of the groups receiving funds to develop technology platforms.
The European firms will collaborate to scale up manufacturing of proprietary silicon chips used in Evonetix's benchtop DNA synthesis platform.
The deal follows a number of recent acquisitions in the animal genomics space for Neogen including Canadian animal genomics firm Delta Genomics Centre.
As 2020 dawns, forensic genomics is poised for growth as companies aim to harness the power of consumer databases coupled with advances in sequencing.
Researchers in academia and industry are showing interest in the scale offered by Inscripta's Onyx platform for genome editing, launched in October.
Researchers around the world said they received shipments of Flongle flow cells that didn't pass the company's quality threshold for working pores.
The firm said it plans to sign between five and 10 additional biopharma collaborations in fiscal year 2020, some with milestone and royalty payment structures.
Novavax has begun a phase III trial of its SARS-CoV-2 vaccine, according to the New York Times.
Vox reports that the Trump Administration may limit student visas for individuals from some countries to two years.
The governor of New York says the state will conduct its own review of any SARS-CoV-2 vaccine, NPR reports.
This week in Science: Neanderthal Y chromosomes replaced by Homo sapiens Y chromosomes, and more.